Low-Dose Clindamycin Achieves 82% Two-Year Success Against Prosthetic Joint Infections
A retrospective cohort study found that low-dose clindamycin, alone or with rifampicin, achieved two-year treatment success in about 82 percent ...
A retrospective cohort study found that low-dose clindamycin, alone or with rifampicin, achieved two-year treatment success in about 82 percent ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.